Neurological disorders

Applied filters

Neurological disorders

Care Setting (5)
- Dentistry (1)
- Paediatrics (1)
- Primary Care (3)
- Trusts (1)
Events (1)
- Past Events (1)
Guidance (10)
- Aseptic services (2)
- Cautions and contraindications (1)
- Excipients (1)
- Formulation (1)
- Intrathecal medicines (2)
- Patient Group Directions (1)
- Prescribing (2)
- Safety in Breastfeeding (2)
- Swallowing difficulties (1)
- Switching (1)
Medicine (10)
- Amantadine (1)
- Baclofen (1)
- Benzylpenicillin (1)
- Bromocriptine (1)
- Cabergoline (1)
- Carbamazepine (1)
- Carbidopa + Levodopa + Entacapone (1)
- Clobazam (1)
- Clonazepam (1)
- Clonidine (1)
- Co-beneldopa (1)
- Co-careldopa (1)
- Diazepam (1)
- Entacapone (1)
- Levodopa + Carbidopa + Entacapone (1)
- Lorazepam (1)
- Melatonin (1)
- Midazolam (1)
- Natalizumab (3)
- Nitrazepam (1)
- Oxazepam (1)
- Pergolide (1)
- Phenytoin (1)
- Pramipexole (1)
- Rasagiline (1)
- Ropinirole (1)
- Rotigotine (1)
- Selegiline (1)
- Sodium valproate (1)
- Temazepam (1)
- Tolcapone (1)
- Zolpidem (1)
- Zopiclone (1)
Medicines planning (3)
- Biosimilars (3)
Publications (1)
- Templates (1)
Specialty (14)
- Anaesthesia and pain (1)
- Infection and infectious diseases (2)
- Mental health and illness (2)
- Neurological disorders (14)

The licence and supporting evidence for natalizumab biosimilar

6 February 2024One licensed natalizumab biosimilar is available: Tyruko. Learn about the licensed indications and supporting evidence.

Baclofen: informing intrathecal risk assessment

11 August 2022Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Using antidepressants for depression in people with epilepsy

14 May 2021Antidepressant use requires special consideration in people with epilepsy. Treating depression in stable epilepsy is covered.

Clonidine: informing intrathecal risk assessment

11 August 2022Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

SPS - Specialist Pharmacy Service

NHS

Neurological disorders

14 results

The licence and supporting evidence for natalizumab biosimilar

Baclofen: informing intrathecal risk assessment

Using antidepressants for depression in people with epilepsy

Clonidine: informing intrathecal risk assessment

Learn more about us or ask for help